● Recruiting

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Condition: Idiopathic Pulmonary Fibrosis (IPF) · Sponsor: InSilico Medicine Hong Kong Limited

PhasePhase 2

Planned participants40

Who can joinAll sexes, 40 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this revised Phase IIa study is to demonstrate safety of INS018\_055 over 12 weeks in adults with Idiopathic Pulmonary Fibrosis (IPF).

This description comes directly from the study's public registry record.

Talk to the study team

Monique Duncan · +86 18817554306 · Insilico-Clinicaltrial@insilico.ai

Carol Salter, MD, PhD · Insilico-Clinicaltrial@insilico.ai

Always discuss trial participation with your own doctor first.

Locations (12)

University of Alabama at Birmingham	Birmingham, Alabama, United States	Recruiting
HonorHealth Research Institute	Scottsdale, Arizona, United States	Recruiting
Keck School of Medicine of USC	Los Angeles, California, United States	Recruiting
Florida Lung Asthma and Sleep Specialist	Celebration, Florida, United States	Recruiting
Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando	Orlando, Florida, United States	Recruiting
Southeastern Research Center	Winston-Salem, North Carolina, United States	Recruiting
University of Oklahoma Health Sciences Center (OUHSC)	Oklahoma City, Oklahoma, United States	Recruiting
Temple University Hospital-Temple Lung Center	Philadelphia, Pennsylvania, United States	Recruiting
Bogan Sleep Consultants, LLC	Columbia, South Carolina, United States	Recruiting
University of Texas Southwestern Medical Center	Dallas, Texas, United States	Recruiting
Metroplex Pulmonary and Sleep Center	McKinney, Texas, United States	Recruiting
Research Centers of America	McKinney, Texas, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05975983